Status:
NOT_YET_RECRUITING
A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Prostate Cancer
Eligibility:
MALE
18-75 years
Phase:
NA
Brief Summary
The search for clinically actionable alterations within the non-metastatic prostate cancer setting has been an overlooked issue so far. Genomic alterations predicting tumor progression or representati...
Eligibility Criteria
Inclusion
- histologically proven diagnosis of low-risk, or high-risk or locally advanced prostate cancer
- high-risk and locally advanced prostate cancer undergoing surgery
- low-risk prostate cancer undergoing active surveillance or surgery
Exclusion
- previous or concomitant malignancies
- patients already undergoing androgen suppression or other medical treatments for prostate cancer
Key Trial Info
Start Date :
August 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 7 2029
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT06875297
Start Date
August 5 2025
End Date
August 7 2029
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Urologia
Roma, Italy, 00168